Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
      
1
2345678
9101112131415
16171819202122
23242526272829
3031     
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More
| 1 |

 
 
  Tags
 
placebo addiction treatment alcohol dependence Journal of Psychopharmacology opioid antagonist recovery network alcohol treatment opiates addict pain pills pain killers alcohol behavioral health substance dependence health insurance medical Opioid Prescribing SD health insurance substance use disorder prescriptions drug addiction double-blind morphine methadone muscle relaxant behavioral health care services methamphetamine placebo-controlled behavioral health care data mining mental health stimulants drug addicts contract opioid abuse bipolar disorder care coaching reducing craving health plan fentanyl communication behavioral healthcare anxiety emergency room predictive modeling sugar narcotic Raymond Anton cigarettes vicodin medical costs treatment ADHD health insurance alcohol drinking hospitalizations withdrawal UnitedHealthcare CIWA relapse pain medication nicotine opioid hospital opiod abuse drug use painkillers cocaine high-utilizing mental illness opiod-based oxycodone diabetes overdose Research Across America cocaine treatment recovery drug abuse ADD suboxone binge drinking randomized sobriety Opioid Treatment OxyContin opioid overdose dependence issues Harold Urschel health reform buprenorphine SD members PTSD chronic pain drinking Catasys Co Occurring Disorders trauma reduction in use over-the-counter substances depression screening codeine medical and behavioral costs physician- patient relations flumazenil stress marijuana prometa methamphetamine dependence smoking relapse prevention identification hydrocodone drug overdose primary care vivitrol social network gabapentin opioid-drug interactions addiction drug treatment urine drug screen Health Care Utilization Opioid Medications facebook substance dependence costs substance dependence depression reduction in craving behavioral healthcare services ER sober OnTrak craving craving score post-traumatic stress disorder psychosocial heroin meth naloxone stratified alcoholism percocet
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414